These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 5774055)

  • 41. Some cardiac effects of 1-allyl-2-benzyl-piperidine hc1, in vitro and in vivo.
    Ferko AP
    Arch Int Pharmacodyn Ther; 1972 Apr; 196(2):363-75. PubMed ID: 5012446
    [No Abstract]   [Full Text] [Related]  

  • 42. [Study of the electrophysiological properties of bretylium tosylate in man].
    Touboul P; Porte J; Huerta F; Delahaye JP
    Arch Mal Coeur Vaiss; 1976 May; 69(5):503-11. PubMed ID: 821420
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparative mechanisms of antiarrhythmic agents.
    Singh BN
    Am J Cardiol; 1971 Aug; 28(2):240-2. PubMed ID: 5560832
    [No Abstract]   [Full Text] [Related]  

  • 44. Bretylium, a Class III Antiarrhythmic, Returns to the Market.
    Thind M; Sullivan RM; Williams RN; Kowey PR
    Am J Cardiol; 2020 Oct; 133():77-80. PubMed ID: 32843146
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The effect of alkyl substitution in drugs. XIX. Synthesis and pharmacological properties of a series of 1-(diarylmethoxy)-3-(isopropylamino)-2-propanol hydrochlorides showing antiarrhythmic activity.
    De Vries J; Nauta WT; Timmerman H; van Hell G; Mulder D
    Arzneimittelforschung; 1968 Sep; 18(9):1200-3. PubMed ID: 5755937
    [No Abstract]   [Full Text] [Related]  

  • 46. Electrophysiologic antagonism of quinidine and bretylium tosylate.
    De Azevedo IM; Wantanabe Y; Dreifus LS
    Am J Cardiol; 1974 May; 33(5):633-8. PubMed ID: 4820895
    [No Abstract]   [Full Text] [Related]  

  • 47. Interaction of calcium, norepinephrine, and bretylium in antagonizing myocardial depression caused by antiarrhythmic drugs.
    Bacaner M
    Mt Sinai J Med; 1970; 37(3):247-55. PubMed ID: 5310011
    [No Abstract]   [Full Text] [Related]  

  • 48. Preparation, local anaesthetic and antiarrhythmic activity of pyrrolidinomethylcyclohexyl esters of alkoxysubstituted phenylcarbamic acids.
    Búciová L; Cizmárik J; Sedlárová E; Racanská E
    Pharmazie; 1995 Aug; 50(8):566-7. PubMed ID: 7568323
    [No Abstract]   [Full Text] [Related]  

  • 49. Mechanism of the inotropic action of bretylium tosylate on the heart.
    Priola DV; Spurgeon HA; Blauw AS; Cannon WB; Dong E
    J Pharmacol Exp Ther; 1973 Oct; 187(1):121-32. PubMed ID: 4746321
    [No Abstract]   [Full Text] [Related]  

  • 50. The cellular electrophysiological effects of tedisamil in human atrial and ventricular fibers.
    Németh M; Virág L; Hála O; Varró A; Kovács G; Thormählen D; Papp JG
    Cardiovasc Res; 1996 Feb; 31(2):246-8. PubMed ID: 8730401
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effects of thiopental and pentobarbital sodium on the transmembrane potentials of the rabbit's atria in special reference to interaction with catecholamine.
    Kiba T
    Jpn J Pharmacol; 1966 Dec; 16(4):368-79. PubMed ID: 5298712
    [No Abstract]   [Full Text] [Related]  

  • 52. The effect of cardiac muscle of two drugs related to amiodarone, L8040 and L8462.
    Vaughan Williams EM; Polster P
    Eur J Pharmacol; 1974 Feb; 25(2):241-7. PubMed ID: 4435026
    [No Abstract]   [Full Text] [Related]  

  • 53. A third class of anti-arrhythmic action. Effects on atrial and ventricular intracellular potentials, and other pharmacological actions on cardiac muscle, of MJ 1999 and AH 3474.
    Singh BN; Vaughan Williams EM
    Br J Pharmacol; 1970 Aug; 39(4):675-87. PubMed ID: 5485144
    [TBL] [Abstract][Full Text] [Related]  

  • 54. On the mechanism of neuromuscular blocking action of bretylium and guanethidine.
    Chang CC; Chen TF; Cheng HC
    J Pharmacol Exp Ther; 1967 Oct; 158(1):89-98. PubMed ID: 4293315
    [No Abstract]   [Full Text] [Related]  

  • 55. The effects of amphotericin B on the ionic currents on frog atrial trabeculae.
    Schanne OF; Ruiz-Ceretti E; Deslauriers Y; Payet D; Soulier P; Demers JM
    J Mol Cell Cardiol; 1977 Nov; 9(11):907-20. PubMed ID: 304107
    [No Abstract]   [Full Text] [Related]  

  • 56. [Bretylium tosylate, a new original anti-arrhythmic agent].
    Warembourg H; Vermeersch M; Pauchant M; Ducloux G; Delebecque H
    Lille Med; 1972 Feb; 17(2):201-4. PubMed ID: 5038050
    [No Abstract]   [Full Text] [Related]  

  • 57. Clinical pharmacology of antiarrhythmic drugs: a review and overview, Part III.
    Singh BN; Cho YW; Kuemmerle HP
    Int J Clin Pharmacol Ther Toxicol; 1981 Jun; 19(6):239-48. PubMed ID: 7030972
    [No Abstract]   [Full Text] [Related]  

  • 58. The effect of calcium in removing the blocking action of bretylium and guanethidine.
    Burn JH; Welsh F
    Br J Pharmacol Chemother; 1967 Sep; 31(1):74-81. PubMed ID: 6058829
    [No Abstract]   [Full Text] [Related]  

  • 59. [Effects of 6-hydroxy-6-methyl-2-heptamine (Heptamine) on the isolated rabbit atria].
    Nose T; Hayashi G; Kowa Y
    Nihon Yakurigaku Zasshi; 1967 Nov; 63(6):433-42. PubMed ID: 4385547
    [No Abstract]   [Full Text] [Related]  

  • 60. A study of the antiarrhythmic and local anaesthetic actions of phencarbamide.
    Madan BR; Madan V; Pendse VK; Gupta RS
    Arch Int Pharmacodyn Ther; 1970 May; 185(1):53-65. PubMed ID: 5470024
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.